Member Info for Brand

Doc, I am of the belief that if P3 replicates P2, the scale up will reminiscent of the vaccine drive of 2021. The product can be licenced for local production in multiple markets at local costs and the ease of administration, long term safety profile and virnal agnostic nature will quickly see SNG approved for a range of uses.

I get where you are coming from with 'the real world', but look at moderna and biontech.

Thank you for sharing :)

And given the size of India's pharma manufacturing industry, you have to expect scaling up local production would be fast and and cost effective.

So, came across this on twitter this evening and it looks to show that trades on SYGGF show on LSE as 'Unknown'

https://twitter.com/FrancoisVerrea3/status/1481692879999451143?t=qgiHJFvkTXij_NKkbpjBow&s=19

Exact same pattern of trades went through this afternoon around 4PM, same value over and over, all Unknown.

Looks like US Market may finally be waking up to Synairgen :)

I came across the same article in Greek this morning, it looks to be doing the rounds. Content and clicks is a funny old game.

Matterhorn,

'Copy and paste job with questionable research including inaccuracies.'

Sounds like Fox news to me! lol

Considering what we've seen for the Pfizer and Merck covid pills, the COPD market, asthma and the potential for influenza etc. If SNG gets anywhere near phase 2 results you've gotta be looking at minimum £25-30B

Smokey, if you've even been involved in updating a website then it's something that will have come up on a regular basis. Usually in a frustrating way, as you're trying to figure out why what you uploaded yesterday isn't showing live.

TL

'Should Labour return to power, we can expect high taxation, with a huge waste of public money on minority groups, as was the case under Blair/Brown.'

We've already got this....

All good Oak, cheers.

I hope you don't mind me re-posting G, I just thought this should have its own thread.

The result muenchen is getting here on his Google search is what happens when a page exists on a website but is not yet made live (or has been taken off live)

So it looks extremely likely that we will soon see details of BARDA funding for Synairgen

gggg21

Today 14:07

Posts: 8,806

Price: 193.40

https://twitter.com/1985muenchen/status/1481623907102863363 this thread and tweet maybe of interest to a few.

I see a few interesting names back on here posting today just like on the dip last week..........hiiiii!

GGGG - all showed up at the exact same time as well. Strange that, isn't it?

The crown jewel in an AZ covid/respiratory spin-off? Maybe a merger of some sort?

https://www.fiercepharma.com/pharma/astrazeneca-weighs-spinning-division-covid-19-vaccine-antibodies-into-separate-company

Vaccine, prophylactic & a brand new wonder drug all under one roof.

If there is one thing we have firmly established, it's that the SP doesn't go up when Poly are buying.

Second that 007

When was it they first bought in? After placing? Pretty damn impressive to gobble up 17% of the company while keeping the sp below 2 quid.

6 months ago this would have sent this board in to rapture..

So nice you posted it twice...

You mean right around the time data would have been unblinded? ;-)

Did you buy any?

Thank you to those that shared their knowledge on THIS one.

(Fat fingers tonight apparently)